Johnson & Johnson Reports 2012 Third-Quarter Results:

J&J’s sales of $17.1Bn for the third quarter of 2012, represent an increase of 6.5% compared to Q3 2011. Synthes product sales contributed 5.8% to worldwide operational sales growth, net of the divestiture of the DePuy trauma business.



Johnson & Johnson Reports 2012 Third-Quarter Results: (via PR Newswire)

NEW BRUNSWICK, N.J., Oct. 16, 2012 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced sales of $17.1 billion for the third quarter of 2012, an increase of 6.5% as compared to the third quarter of 2011. Operational results increased 10.8% and the negative impact of currency was 4.3%. Domestic…



published: October 16, 2012 in: Financial, Johnson & Johnson

Most read

Latest

^